FOGHORN THERAPEUTICS
Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order.By manipulating this system with our unique Gene Traffic ControlTM platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease.With Gene Traffic ControlTM Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.
FOGHORN THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Life Science Therapeutics
Founded:
2015-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.foghorntx.com
Total Employee:
51+
Status:
Active
Contact:
617-586-3100
Email Addresses:
[email protected]
Total Funding:
111 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Sitelinks Search Box Euro Microsoft Exchange Online
Similar Organizations
EPIX Therapeutics
EPIX Therapeutics develops and commercializes microwave radiometry-based products for electrophysiology tests.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Ally Therapeutics
Ally Therapeutics solves the immune response barriers for gene therapy.
Ambrx
Ambrx develops protein therapeutics that preserve potency, reduce dosing frequency, and improve homogeneity of the drug substance.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
BeneVir Biopharm
Maryland startup BeneVir is developing immunotherapy viruses that rid the body of two types of tumor cells.
Bicara Therapeutics
Bicara Therapeutics is developing a pipeline of bifunctional antibodies that exploit the recent advances in immuno-oncology.
Bioline AgroSciences
Bioline produces and markets a wide range of invertebrate biological control organisms which are used for control of insect pests.
Bionaut Labs
Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality.
CDx Diagnostics
CDx Diagnostics develops and provides diagnostic systems intended to prevent cancer by detecting pre-cancerous cells.
FoxBio
FoxBio is a Company that will develop Antoxerene’s collection of small molecules that target senescent cells.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Ginkgo Bioworks
Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets.
HotSpot Therapeutics
HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.
Iconic Therapeutics
Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells.
ImCheck Therapeutics
ImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules.
Jounce Therapeutics
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
LNC Therapeutics
LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases.
Metabolic Solutions Development
Metabolic Solutions Development develops innovative therapeutics based on a novel pharmacological method to treat type two diabetes.
Nereid Therapeutics
Nereid Therapeutics is discovering new disease treatments by applying research and technologies in biomolecular condensates.
OncoHealth
OncoHealth designs screening devices that detects and diagnoses cancer.
Tenaya Therapeutics
Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.
Tissue Genesis
Tissue Genesis is an innovator of advanced tissue engineering and cell therapy solutions.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Irving Investors
Irving Investors investment in Venture Round - Foghorn Therapeutics
Invus
Invus investment in Venture Round - Foghorn Therapeutics
Casdin Capital
Casdin Capital investment in Venture Round - Foghorn Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Venture Round - Foghorn Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-10 | Foghorn Therapeutics Announces Chief Scientific Officer Succession |
Official Site Inspections
http://www.foghorntx.com Semrush global rank: 4.12 M Semrush visits lastest month: 2.93 K
Unable to get host informations!!!
